John Higgins, MD
Clinical Pathology/Laboratory Medicine · Boston, MANPI 1639241409
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,090 of the $10,090 with a category attached, or 100.0%. Cepheid accounts for 82.2% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $6,095 and has fallen 70.5% since, to $1,800 in 2022.
Across 4 payments — averaging $2522.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cepheid$8K
- Instrumentation Laboratory Company$2K
Across 6 payments — averaging $23,183 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$139K
What the payments were for
- Consulting fees$10,090100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cepheid | 3 | $8,290 |
| Instrumentation Laboratory Company | 1 | $1,800 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENEXPERT$8,290
How this compares
$10,090 in reported general payments places this provider in the 80th percentile of 27 clinical pathology/laboratory medicine providers in Massachusetts.
See all clinical pathology/laboratory medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in Boston
- Christopher StowellBoston$55K
- Matthew MeyersonBoston$22K
- Stacy MelansonBoston$21K
- Anders BergBoston$13K
- Petr JarolimBoston$8K
- Sacha UljonBoston$8K
- Dongsheng XuBoston$6K
- Ileana Lopez PlazaBoston$5K
- Steven SloanBoston$4K
- Agata SmogorzewskaBoston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.